Edratide

Generic Name: Edratide

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₁₁H_₁₄₉N_₂₇O_₂₈

CAS Number: 433922-67-9

Unique Ingredient Identifier: 38PLP07BKC

Background: Edratide is under investigation in clinical trial NCT00203151 (A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus

Phase 2

Terminated

Conditions: Systemic Lupus Erythematosus

Interventions: Drug: edratide

First Posted Date: 2005-09-20

Last Posted Date: 2011-04-12

Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Target Recruit Count: 340

Registration Number: NCT00203151

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy